AIE's Latest News



AIE presents "i-Biomarker™ CaDx Detects 99-100% of Lung Cancers" at the International Conference on Cancer Research and Clinical Trials (CRCT-2023)





Our company recently presented the abstract "i-Biomarker™ CaDx Detects 99-100% of Lung Cancers" at the International Conference on Cancer Research and Clinical Trials (CRCT-2023) hosted in Dubai. The abstract will be published soon in the British Journal of Cancer Research with a permanent DOI number!


Check out the attached presentation and discover more about our groundbreaking research! content is not displayed due to your current cookie settings. Click on the cookie policy (functional and marketing) to agree to the cookie policy and view the content. You can find out more about this in the privacy policy.




Exciting News - Chapter Accepted!


Our team is proud to announce that our chapter proposal "i-Biomarker - Multi Cancer Early Detection as a Data Science with AI Problem" has been accepted for publication in the upcoming book "Molecular Diagnostics of Cancer."


We are thrilled to have the opportunity to share our groundbreaking research and expertise with a wider audience.



An European Project aiming to Optimise and predict antidepressant efficacy for patient with major depressive disorders using multi-omics analysis and AI-predictive tools.


31 January 2023

The Kick-off meeting of the European project OPADE was held at the EBRIS Foundation (EUROPEAN BIOMEDICAL RESEARCH INSTITUTE OF SALERNO) on 23-24th January.  The project will have a duration of 54 months, ending on 31 May 2027.

The project general objective is to identify key biomarkers that support the decision-making process of the healthcare providers. The project focuses on the microbiota – brain -axis which plays a major role in mental health and in particular Major depression disorder. Through clinical investigations, the consortium partners will study the combination between genetics, epigenetics, microbiome and inflammatory networks.

OPADE project is 100% funded by the European Union (Horizon Europe Grant Agreement 101095436). Scientifically coordinated by EBRIS Foundation, it integrates a consortium of research centres, hospitals and enterprises from ten different countries. The consortium is completed by The CEINGE BIOTECNOLOGIE AVANZATE SCARL (Italy), PERSEUS BIOMICS (Belgium), FUNDACIO EURECAT (Spain), ARTIFICIAL INTELLIGENCE EXPERT SRL (Romania), MAMA HEALTH TECHNOLOGIES GMBH (Germany), PROTOBIOS OU (Estonia), CEPHALGO (France), BIOKERALTY RESEARCH INSTITUTE AIE (Spain),  FUNDACION UNIVERSITARIA SANITAS (Colombia), UNIVERSITA DEGLI STUDI DI SIENA (Italy), STICHTING UNIVERSITAIRE EN ALGEMENE KINDER - EN JEUGDPSYCHIATRIE NOORD-NEDERLAND (The Netherlands), FUNDACIO INSTITUT D'INVESTIGACIO BIOMEDICA DE GIRONA DOCTOR JOSEP TRUETA (Spain) and ISTANBUL MEDIPOL UNIVERSITESI (Turkey).


During this meeting researchers from the different organizations discussed the key issues to be addressed during the first year and the administrative procedures to ensure the success of this innovative project.




AIE was awarded with a Seal of Excellence by EIC Jury


The Seal of Excellence (SoE) certificate recognises the value of the proposal and helps other funding bodies take advantage of the high quality Commission evaluation process.



AIE places 2nd in Romania's Top SMEs in domain of Innovation & Research


 AIE was named 2nd in profit in Romania's top for SMEs focused on Innovation and Research activities   




AIE was included in the 3rd edition of the
"Top Disruptors in Healthcare" Report


Our company is among the top disruptors in the innovative medical startups in CEE region. The report was officially published on June 14, 2022 during the international „AI in Health” Conference.



OPADE: Optimise and predict antidepressant efficacy for people with major depressive disorders using multi-omics analysis


AIE is part of the consortium for OPADE project. The project won the HORIZON-HLTH-2022-TOOL-11 Call in August and will begin in early 2023.   




AIE passed the 2nd stage for EIC Accelerator


On 18 July 2022 AIE recieved the GO for the 2nd stage of the EIC Accelerator project VINCI. Winning this 6M grant & investment will help us bring the Breast Cancer Early Detection Test to the market.




Patent Pending


The invention supporting our Multi-Cancer Early Detection test "METHOD AND SYSTEM FOR MULTI-CANCER MANAGEMENT IN SUBJECT" is Patent Pending since 4th of July 2022.




Artificial Intelligence in the World of Oncology

Indian Journal of Cancer


Dr. Alexandru Floares, President of Solutions of Artificial Intelligence Applications (SAIA) and CEO of Artificial Intelligence Expert and OncoPredict, Romania opines that “Statistical Methods are still dominant even though there is a paradigm shift in the use of artificial intelligence in oncology. It is not a smooth evolution from traditional statistical methods to artificial intelligence.”




Human Intelligence and AI for Oncology advancement

Vatican News


Our CEO, Dr. Alexandru Floares, was an invited speaker at a 3-day workshop organized by the Pontifical Academy for Life on Ethics and Artificial Intelligence (AI). He spoke to Vatican Radio on the potential for larger strides in the field of oncology and medical research through the efficiency that AI provides.




Artificial intelligence enhances cancer diagnostic testing

EU CORDIS: News article


The AI-MICADIS project developed and tested an extremely accurate, non-invasive tool for early detection and diagnosis of multiple cancer types.


Local Startups competitions

Startarium : Top 10 Start-ups in Romania

Our company participated in our national Start-ups Competition, Startarium, organized by Impact Hub Bucharest. 
There we managed to reach the final, where AIE was placed in the top 10 start-ups from Romania in 2019.



Evenimentul Anului în Industria Smart City - Gala Smart City Industry Awards 2020

Smart City Industry Awards, eveniment organizat de Asociația Română pentru Smart City, a ajuns la cea de-a 5-a ediție! In calitate de parteneri ai evenimentului, vă așteptăm live, online, în 20 decembrie 2020, de la ora 20:00.

Ediția 2020 a galei Smart City Industry Awards va premia acele persoane/instituții/companii care au știut să se adapteze contextului pandemic actual, să digitalizeze, să implice cetățenii în rezolvarea problemelor și în actul administrativ și să implementeze tehnologii și soluții inovatoare care să ajute comunitățile să traverseze mai ușor aceste vremuri dificile. Marele câștigător al Galei SCIA 2019, domnul Mihai Chirica, Primarul Municipiului Iași, este Președintele Juriului pentru ediția a V-a a Galei Smart City Industry Awards 2020.